The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women
- 1 July 1995
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 10 (7), 1068-1075
- https://doi.org/10.1002/jbmr.5650100711
Abstract
The etiology of age‐related bone loss is unclear but both lack of exercise and dietary calcium deficiency have been implicated in its causation. This 2‐year randomized placebo‐controlled study was designed to examine the effects of increased dietary calcium and exercise in 168 women who were more than 10 years postmenopausal. The subjects were randomized into one of 4 groups: placebo, milk powder containing 1 g of calcium, calcium tablets 1 g/night, and calcium tablets 1 g/night and an exercise regimen. The exercise group aimed to undertake 4 h of extra weight‐bearing exercise per week and were undertaking 10% more activity than other groups at 2 years. Bone mineral density at the lumbar spine, three hip sites, and two sites of the tibia close to the ankle joint were measured at 6 month intervals. Dietary intake was evaluated by a weighed food record, exercise was evaluated by an exercise diary, and blood and urine samples were obtained to examine effects on calcium homeostasis. Individual data points were compared using repeated measures ANOVA and least squares regression. Calcium supplementation by either the calcium tablets or the milk powder resulted in cessation of bone loss at the intertrochanteric hip site (placebo, calcium tablets, calcium and exercise, milk powder −0.81, +0.17, +0.23, and +0.07% per year, respectively; p < 0.05 for all supplementation groups compared with placebo) with similar results at the trochanteric hip site. The calcium and exercise group had less bone loss at the femoral neck site when compared with calcium supplementation alone (placebo, calcium tablets, calcium and exercise, milk powder −0.67, −0.18, +0.28, and −0.18% per year, respectively; p < 0.05 for calcium and exercise compared with calcium alone). There was a significant reduction in the rate of bone loss at the ultradistal site of the tibia (placebo, calcium tablets, calcium and exercise, milk powder −2.5, −1.6, −1.0, and −1.5% per year, respectively; p < 0.05 for all supplementation groups compared with placebo). There was no significant bone loss at the spine site in any group. These data support the implementation of a simple public health regimen to prevent age‐related bone loss with calcium supplementation either by calcium tablet or by milk powder. The extra effect of exercise plus calcium at the femoral neck site suggests a site‐specific effect of physical activity on bone density in addition to its possible effect to prevent fracture by maintenance of muscle strength and coordination. (Keywords
Funding Information
- NHMRC
- Rotary Foundation of Australia
This publication has 26 references indexed in Scilit:
- Factors affecting the assay of urinary 3–hydroxy pyridiniurn crosslinks of collagen as markers of bone resorptionEuropean Journal of Clinical Investigation, 1993
- SERUM FREE 1,25‐DIHYDROXYVITAMIN D AND THE FREE 1,25‐DIHYDROXYVITAMIN D INDEX DURING A LONGITUDINAL STUDY OF HUMAN PREGNANCY AND LACTATIONClinical Endocrinology, 1990
- Calcium supplementation of the diet: justified by present evidence.BMJ, 1990
- Calcium absorption in women: Relationships to Calcium intake, Estrogen status, and ageJournal of Bone and Mineral Research, 1989
- Calcium supplementation of the diet--II.BMJ, 1989
- Calcium supplementation of the diet--I.BMJ, 1989
- Regulation of bone mass by mechanical strain magnitudeCalcified Tissue International, 1985
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- The relationship of functional stress and strain to the processes of bone remodelling. An experimental study on the sheep radiusJournal of Biomechanics, 1979
- Bone and soft tissue changes with oral phosphate supplementsJournal of Clinical Investigation, 1972